Noticias de QNCX_US

Noticias del mercado

Últimas noticias sobre QNCX_US — 158 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: QNCX_US ✕ 158 resultados
09/04/2026 QNCX_US — Stock Titan
Quince Therapeutics (QNCX) enacts 1-for-10 reverse split, 16.3M shares post-split
09/04/2026 QNCX_US — MarketScreener
Quince Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
09/04/2026 QNCX_US — TipRanks
Quince Therapeutics Announces 1-for-10 Reverse Stock Split
09/04/2026 QNCX_US — Minichart
Quince Therapeutics, Inc. Files Form 8-K Announcing Certificate of Amendment and Company Details
09/04/2026 QNCX_US — Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Cue Biopharma (NASDAQ:CUE), Cuprina Holdi
08/04/2026 QNCX_US — Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
08/04/2026 QNCX_US — ChartMill
Curious about the most active stocks on Wednesday?
08/04/2026 QNCX_US — Benzinga
9 Health Care Stocks Moving In Wednesday's Pre-Market Session
07/04/2026 QNCX_US — ChartMill
Wondering what's happening in today's after-hours session?
07/04/2026 QNCX_US — ChartMill
Wondering what's happening in today's after-hours session?
07/04/2026 QNCX_US — Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session - Alvotech (NASDAQ:ALVO), Artelo Bioscienc
03/04/2026 QNCX_US — TradingView
Quince Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
03/04/2026 QNCX_US — haiphong.gov.vn
QNCX Stock Analysis: Quince Therapeutics Inc. 3.23% drop to $0.1, biotech performance assessment
02/04/2026 QNCX_US — news.google.com
Will Quince Therapeutics (QNCX) Stock Miss Expectations | Price at $0.99, Down 3.23% - Shared Buy Zones
02/04/2026 QNCX_US — haiphong.gov.vn
Will Quince Therapeutics (QNCX) Stock Miss Expectations | Price at $0.99, Down 3.23% - Shared Buy Zones
01/04/2026 QNCX_US — Stock Titan
Quince Therapeutics (QNCX) delays 2025 10-K after failed Phase 3; seeks 15-day extension
01/04/2026 QNCX_US — TipRanks
Quince Therapeutics Delays Annual 10-K Filing
31/03/2026 QNCX_US — The Globe and Mail
Quince Therapeutics Eliminates EIB Debt, Boosts Flexibility
30/03/2026 QNCX_US — MSN
Quince Therapeutics settles $16.4M debt with $5.5M payment
30/03/2026 QNCX_US — MSN
Quince Therapeutics settles $16.4M debt with $5.5M payment

Página 7 de 8

keyboard_arrow_up